Cargando…

The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehoorne, Joke, Joos, Rik, Wouters, Carine, Swart, Joost F., Consolaro, Alessandro, Bovis, Francesca, Ruperto, Nicolino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893729/
https://www.ncbi.nlm.nih.gov/pubmed/29637362
http://dx.doi.org/10.1007/s00296-018-3935-2
_version_ 1783313363491618816
author Dehoorne, Joke
Joos, Rik
Wouters, Carine
Swart, Joost F.
Consolaro, Alessandro
Bovis, Francesca
Ruperto, Nicolino
author_facet Dehoorne, Joke
Joos, Rik
Wouters, Carine
Swart, Joost F.
Consolaro, Alessandro
Bovis, Francesca
Ruperto, Nicolino
author_sort Dehoorne, Joke
collection PubMed
description The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Flemish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 100 JIA patients (8% systemic, 33% oligoarticular, 24% RF negative polyarthritis, 35% other categories) and 99 healthy children, were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Flemish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
format Online
Article
Text
id pubmed-5893729
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58937292018-04-16 The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Dehoorne, Joke Joos, Rik Wouters, Carine Swart, Joost F. Consolaro, Alessandro Bovis, Francesca Ruperto, Nicolino Rheumatol Int Validation Studies The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Flemish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach’s alpha, interscale correlations, test–retest reliability, and construct validity (convergent and discriminant validity). A total of 100 JIA patients (8% systemic, 33% oligoarticular, 24% RF negative polyarthritis, 35% other categories) and 99 healthy children, were enrolled in two centres. The JAMAR components discriminated well healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Flemish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research. Springer Berlin Heidelberg 2018-04-07 2018 /pmc/articles/PMC5893729/ /pubmed/29637362 http://dx.doi.org/10.1007/s00296-018-3935-2 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Validation Studies
Dehoorne, Joke
Joos, Rik
Wouters, Carine
Swart, Joost F.
Consolaro, Alessandro
Bovis, Francesca
Ruperto, Nicolino
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title_full The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title_fullStr The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title_full_unstemmed The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title_short The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
title_sort flemish version of the juvenile arthritis multidimensional assessment report (jamar)
topic Validation Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893729/
https://www.ncbi.nlm.nih.gov/pubmed/29637362
http://dx.doi.org/10.1007/s00296-018-3935-2
work_keys_str_mv AT dehoornejoke theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT joosrik theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT wouterscarine theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT swartjoostf theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT consolaroalessandro theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT bovisfrancesca theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT rupertonicolino theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT theflemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT dehoornejoke flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT joosrik flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT wouterscarine flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT swartjoostf flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT consolaroalessandro flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT bovisfrancesca flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT rupertonicolino flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar
AT flemishversionofthejuvenilearthritismultidimensionalassessmentreportjamar